Product Information
CLORAZEPATE 15 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $1.0331 per EA under NDC 13107032101. Its NADAC has been published 226 times since Mar 2, 2022.
Strength
15 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107032101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLORAZEPATE DIPOTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA071858On Market Since
7/17/1987
Pharmacological Classes
Price Statistics
The NADAC for CLORAZEPATE 15 MG TABLET has been published 226 times since Mar 2, 2022, and over the history we have for it it has declined 63.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0331 per EA |
|---|---|
| All-time high | $3.1030 (Jul 13, 2022) |
| All-time low | $0.6724 (Jun 19, 2024) |
| 52-week high | $1.7543 |
| 52-week low | $1.0331 |
| Median price | $1.4754 |
| Average price | $1.6627 |
| Largest weekly change | +94.5% (Mar 20, 2024) |
| Weeks tracked | 226 |
| Tracking since | Mar 2, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the CLORAZEPATE DIPOTASSIUM market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CLORAZEPATE 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLORAZEPATE 15 MG TABLET, manufactured by Aurolife Pharma LLC, is $1.0331 per EA (NDC 13107032101), effective Jun 24, 2026.
How has the price of CLORAZEPATE 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLORAZEPATE 15 MG TABLET has declined 63.8%. It has been tracked across 226 weekly CMS publications since Mar 2, 2022.
What are the highest and lowest recorded NADAC prices for CLORAZEPATE 15 MG TABLET?
Since Mar 2, 2022, the NADAC for CLORAZEPATE 15 MG TABLET has ranged from a low of $0.6724 (Jun 19, 2024) to a high of $3.1030 (Jul 13, 2022), with a median of $1.4754 per EA.
Are there cheaper alternatives to CLORAZEPATE 15 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CLORAZEPATE 15 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures CLORAZEPATE 15 MG TABLET?
CLORAZEPATE 15 MG TABLET (NDC 13107032101) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification